Educational Videos and Resources
Our physicians and medical staff are not just expert caregivers, but also passionate educators. Through our series of educational videos and other resources, we are dedicated to providing our patients easy access to the most up-to-date information that they can use to stay well-informed.
As each patient's situation and medical history differ, none of these videos should be used as a substitute for medical advice or used solely to make medical decisions. Please speak to your provider if you have questions or concerns.
Mobile users: Click "Watch Now" to start the first video in the playlist OR swipe back and forth to view individual videos.
Roe v. Wade FAQs
SPECIAL CONTENT:
On behalf of the OB/GYN department, Dr. Sharma and Dr. Masana joined patient, Kaia, to answer some of the most frequently asked questions about Roe v. Wade and the Dobbs v. Jackson decision. They want you to know that OB/GYNs are still here for you and able to provide resources and care before and after an abortion.
More Resources:
Mifepristone FAQs
Video Content Map:
0:25 - What is Roe v. Wade?
0:43 - What is Dobbs v. Jackson?
1:17 - What does this mean for Wisconsin?
2:37 - What is the practice for miscarriage/ectopic pregnancies?
3:37 - What can OB/GYN do if I want an abortion?
4:37 - Can I get in legal trouble for an out-of-state abortion?
5:14 - Can abortion pills still be mailed to me?
6:09 - Are "home abortions" safe and effective?
7:47 - What should I do in a reproductive health emergency?
8:56 - What resources are available for mental health?
SPECIAL CONTENT:
TW: Gendered Language—See Disclaimer.
Many of us know and love someone who has experienced a miscarriage. While absolutely devastating for countless parents, 10-20% of pregnancies end in miscarriage, with 80% occurring before the 12th week of pregnancy. Unfortunately, after a recent ruling in Texas, Mifepristone, an FDA-approved medication used for over two decades to more safely and effectively manage miscarriage, has been called into question. Losing access to this medication means physicians are left with more invasive (surgical), risky, and less effective treatment for miscarrying patients.
Dr. Sharma and Dr. Masana teamed up to provide the facts on just how VITAL Mifepristone is for reproductive healthcare.
DISCLAIMER:
Our OB/GYN department provides care to ALL patients regardless of their sexual or gender identity, and both support and validate ALL under our care on their unique journeys. The use of the word “woman” in this sense is to allow this CRUCIAL message to reach those who may be unaware or unsure about the impact this ruling has on the reproductive health of ALL patients who may become pregnant.